aripiprazole 5 mg
1 INDICATIONS & USAGE Aripiprazole Oral Tablets, are indicated for the treatment of: Schizophrenia Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder Adjunctive Treatment of Major Depressive Disorder Irritability Associated with Autistic Disorder Treatment of Tourette’s Disorder Aripiprazole tablets are an atypical antipsychotic. The oral formulation is indicated for: Schizophrenia ( 14.1 ) Acute Treatment of Manic and Mixed Episodes associated with Bipolar I ( 14.2 ) Adjunctive Treatment of Major Depressive Disorder ( 14.3 ) Irritability Associated with Autistic Disorder ( 14.4 ) Treatment of Tourette’s disorder ( 14.5 )
ascend laboratories, llc
RECTANGLE BLUE ARI 5
ARI 5 RECTANGLE BLUE
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
ARIPIPRAZOLE Tablets, USP have markings on one side and are available in the strengths and packages listed in Table 32. Table 32:
ARIPIPRAZOLE Tablets, USP Presentations Tablet Strength Tablet Color/Shape Tablet Markings Pack Size NDC Code 2 mg green modified rectangle “ARI” and “2” 30’s HDPE Container 67877-430-03 100’s HDPE Container 67877-430-01 500’s HDPE Container 67877-430-05 10’s blister pack 67877-430-33 Carton pack of 100 tablets (10 × 10’s blister pack) 67877-430-38 7’s blister pack 67877-430-32 Carton pack of 7 tablets (1 × 7’s blister pack) 67877-430-32 5 mg blue modified rectangle “ARI” and “5” 30’s HDPE Container 67877-431-03 100’s HDPE Container 67877-431-01 500’s HDPE Container 67877-431-05 10’s blister pack 67877-431-33 Carton pack of 100 tablets (10 × 10’s blister pack) 67877-431-38 7’s blister pack 67877-431-32 Carton pack of 7 tablets (1 × 7’s blister pack) 67877-431-32 10 mg pink modified rectangle “ARI” and “10” 30’s HDPE Container 67877-432-03 100’s HDPE Container 67877-432-01 500’s HDPE Container 67877-432-05 10’s blister pack 67877-432-33 Carton pack of 100 tablets (10 × 10’s blister pack) 67877-432-38 7’s blister pack 67877-432-32 Carton pack of 7 tablets (1 × 7’s blister pack) 67877-432-32 15 mg yellow round “ARI” and “15” 30’s HDPE Container 67877-433-03 100’s HDPE Container 67877-433-01 500’s HDPE Container 67877-433-05 10’s blister pack 67877-433-33 Carton pack of 100 tablets (10 × 10’s blister pack) 67877-433-38 7’s blister pack 67877-433-32 Carton pack of 7 tablets (1 × 7’s blister pack) 67877-433-32 20 mg white to off-white round “ARI” and “20” 30’s HDPE Container 67877-434-03 100’s HDPE Container 67877-434-01 500’s HDPE Container 67877-434-05 10’s blister pack 67877-434-33 Carton pack of 100 tablets (10 × 10’s blister pack) 67877-434-38 30 mg pink round “ARI” and “30” 30’s HDPE Container 67877-435-03 100’s HDPE Container 67877-435-01 500’s HDPE Container 67877-435-05 10’s blister pack 67877-435-33 Carton pack of 100 tablets (10 × 10’s blister pack) 67877-435-38 16.2 Storage Store at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
More pills like RECTANGLE ARI 5